Immunogenicity and Safety of a Quadrivalent Plant-derived Virus Like Particle Influenza Vaccine Candidate - Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults

Pillet S et al. PLoS One 2019;14(6):e0216533.

Immunogenicity and Safety of a Quadrivalent Plant-derived Virus Like Particle Influenza Vaccine Candidate – Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults